missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ BRAF35 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5104366
Description
Antibody detects endogenous levels of total HMG20B.
Required for correct progression through G2 phase of the cell cycle and entry into mitosis. Required for RCOR1/CoREST mediated repression of neuronal specific gene promoters.Spécifications
| BRAF35 | |
| Polyclonal | |
| Unconjugated | |
| BRAF | |
| AW610687; BRAF25; BRAF35; BRCA2-associated factor 35; fc85b02; FLJ26127; high mobility group 20 B; high mobility group 20B; high mobility group box domain containing; high mobility group protein 20 B; high-mobility group 20B; HMG box domain containing 2; HMG box-containing protein 20B; HMG domain-containing protein 2; HMG domain-containing protein HMGX2; HMG20B; Hmgx2; HMGXB2; hypothetical protein LOC553572; PP7706; pp8857; si:dkey-110c1.6; SMARCE1R; SMARCE1-related protein; SOXL; Sox-like transcriptional factor; Structural DNA-binding protein BRAF35; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related; LOW QUALITY PROTEIN: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related; SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E, member 1-related; Unknown (protein for MGC:134468); wu:fc85b02; zgc:110001 | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 10362, 673 | |
| -20°C | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| P15056, Q9P0W2 | |
| BRAF, HMG20B | |
| A synthesized peptide derived from human HMG20B(Accession Q9P0W2), corresponding to amino acid residues R34-R84. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |